全文获取类型
收费全文 | 2566篇 |
免费 | 238篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 56篇 |
妇产科学 | 18篇 |
基础医学 | 200篇 |
口腔科学 | 161篇 |
临床医学 | 333篇 |
内科学 | 334篇 |
皮肤病学 | 46篇 |
神经病学 | 162篇 |
特种医学 | 128篇 |
外科学 | 208篇 |
综合类 | 211篇 |
一般理论 | 1篇 |
预防医学 | 609篇 |
眼科学 | 52篇 |
药学 | 141篇 |
21篇 | |
中国医学 | 33篇 |
肿瘤学 | 103篇 |
出版年
2024年 | 1篇 |
2023年 | 76篇 |
2022年 | 74篇 |
2021年 | 168篇 |
2020年 | 203篇 |
2019年 | 136篇 |
2018年 | 118篇 |
2017年 | 129篇 |
2016年 | 97篇 |
2015年 | 129篇 |
2014年 | 186篇 |
2013年 | 230篇 |
2012年 | 150篇 |
2011年 | 162篇 |
2010年 | 115篇 |
2009年 | 121篇 |
2008年 | 100篇 |
2007年 | 100篇 |
2006年 | 83篇 |
2005年 | 78篇 |
2004年 | 65篇 |
2003年 | 63篇 |
2002年 | 47篇 |
2001年 | 39篇 |
2000年 | 31篇 |
1999年 | 29篇 |
1998年 | 11篇 |
1997年 | 19篇 |
1996年 | 15篇 |
1995年 | 12篇 |
1994年 | 8篇 |
1993年 | 7篇 |
1992年 | 4篇 |
1991年 | 4篇 |
1990年 | 5篇 |
1989年 | 8篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有2841条查询结果,搜索用时 15 毫秒
1.
《Research in social & administrative pharmacy》2022,18(9):3492-3500
BackgroundPolypharmacy is commonly related to poor drug adherence, decreased quality of life and inappropriate prescribing in eldery. Furthermore, this condition also leads to a higher utilization of health services resources, due to the increased risk of adverse drug events, length of stays in hospitals and readmissions rates after discharge.ObjectiveThis Systematic Review aimed to synthesize the current evidence that evaluates pharmaceutical services on polymedicated patients, from an economic perspective.MethodsSystematic searches were conducted in MEDLINE, SCOPUS and Cochrane Library databases to identify studies that were published until January 2021. Experimental and observational studies were included in this review, using strict inclusion/exclusion criteria and were assessed for quality using the following tools: RoB and ROBINS-I. Two independent reviewers selected the articles and extracted the data.Results3,662 articles were retrieved from the databases. After the screening, 18 studies were included: 9 experimental and 9 observational studies. The studies reported that the integration of the pharmacist as a member of the healthcare team provides an optimized use of pharmacotherapy to polymedicated patients and contributes to health promotion, providing reduction of spending on medication, reduction of expenses related to emergency care and hospitalizations and other medical expenses. The ECRs made cost-effectiveness or cost-benefit analysis, and most of the Non Randomized studies had statistically significant cost savings even considering the expenses of pharmaceutical assistance. Experimental studies reported a cost reduction varying between US$ 193 to US$ 4,966 per patient per year. Furthermore, observational studies estimated a cost reduction of varying from US$ 3 to US$ 2,505 per patient per year. The cost savings are related to decrease in emergency visits and hospitalizations, through pharmacist intervention (medication review and pharmacotherapy follow-up).ConclusionsConsidering the set of studies included, pharmaceutical care services directed to polymedicated patients may cooperate to save financial resources. Most of the interventions showed positive economic trends and also contributed to improving clinical parameters and quality of life. However, due to the majority of the studies having exploratory or qualitative methodology, it is essential to carry out more robust studies, based on full economic evaluation. 相似文献
2.
Given that the global population of elderly individuals is expanding and the difficulty of recovery, hip fractures will be a huge challenge and a critical health issue for all of humanity. Although people have spent more time at home during the coronavirus disease 2019 (COVID-19) pandemic, hip fractures show no sign of abating. Extensive studies have shown that patients with hip fracture and COVID-19 have a multifold increase in mortality compared to those uninfected and a more complex clinical condition. At present, no detailed research has systematically analyzed the relationship between these two conditions and proposed a comprehensive solution. This article aims to systematically review the impact of COVID-19 on hip fracture and provide practical suggestions. We found that hip fracture patients with COVID-19 have higher mortality rates and more complicated clinical outcomes. Indirectly, COVID-19 prevents hip fracture patients from receiving regular medical treatment. With regard to the problems we encounter, we provide clinical recommendations based on existing research evidence and a clinical flowchart for the management of hip fracture patients who are COVID-19 positive. Our study will help clinicians adequately prepare in advance when dealing with such patients and optimize treatment decisions. 相似文献
3.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(9):554-560
AimsThe Short Course Oncology Treatment (SCOT) trial indicated that 3 months of adjuvant doublet chemotherapy was non-inferior to 6 months of treatment for patients with colorectal cancer, with considerably less toxicity. The SCOT trial results were disseminated in June 2017. The aim of this study was to understand if SCOT trial findings were implemented in Scotland.Materials and methodsA retrospective analysis was carried out on a dataset derived from a source population of 5.4 million people. Eligible patients were those with stage II or III colorectal cancer who received adjuvant chemotherapy. Logistic regression was applied to understand the extent of practice change to a 3-month adjuvant chemotherapy duration after the SCOT trial results were disseminated. Interrupted time series analysis was used to visualise differences in prescribing trends before and after June 2017 for the overall cohort, and by SCOT trial eligibility.ResultsIn total, 2310 patients were included in the study; 1957 and 353 treated pre- and post-June 2017, respectively. The median treatment duration decreased from 21 weeks (interquartile range 14–24) prior to June 2017 to 12 weeks (interquartile range 12–21 weeks) after June 2017 (P < 0.001). The proportion of patients receiving over 3 months of adjuvant treatment decreased from 75% to 42% (P < 0.001). This change was most noticeable for patients who met the SCOT trial eligibility criteria, and specifically for those with low-risk stage III disease and those treated with capecitabine and oxaliplatin (CAPOX). Although practice change occurred in all locations, there were differences between regions that could be explained by pre-SCOT trial prescribing trends.DiscussionA significant change in chemotherapy prescribing occurred after dissemination of the SCOT trial results. National, real-world data can be used to capture the extent of implementation of clinical trial results. In this case, implementation was aligned with clinical trial subgroup findings. This type of analysis could be conducted to evaluate the impact of other clinical trials. 相似文献
4.
目的了解乳腺癌患者癌因性疲乏(cancer-related fatigue, CRF)现状,并分析其影响因素。方法采用横断面调查方法,向乳腺癌患者发放调查问卷,按照IDC-10诊断标准判断是否存在CRF,根据Piper疲乏量表中文修订版(Revised Piper Fatigue Scale, RPFS)得分评价疲乏程度,调查乳腺癌患者CRF的发生情况,并分析其影响因素。结果1 192例患者完成了全部调查问卷,乳腺癌患者发生CRF为668例(占56.04%);以轻、中度疲乏为主,分别占23.95%、55.24%,其中感觉维度得分最高。单因素分析结果显示,文化程度、乳腺癌病程、肿瘤分期、化疗周期、疼痛、上肢水肿、白细胞减少、恶心呕吐、贫血、潮热盗汗、失眠与乳腺癌患者CRF的发生有关(P<0.05);多因素Logistic回归分析显示,乳腺癌肿瘤分期、疼痛、白细胞减少、恶心呕吐、潮热盗汗、失眠是CRF发生的危险因素(P<0.05),病程是其保护因素(P<0.05)。CRF认知调查显示,乳腺癌患者对CRF认知度低,医护人员对其宣教度低。结论乳腺癌患者发生CRF较为普遍,以轻、中度疲乏为主;乳腺癌肿瘤分期、疼痛、白细胞减少、恶心呕吐、潮热盗汗、失眠是影响患者CRF的危险因素;乳腺癌患者对CRF认知度低。 相似文献
5.
《Value in health》2022,25(3):340-349
ObjectivesThis study aimed to systematically review recent health economic evaluations (HEEs) of artificial intelligence (AI) applications in healthcare. The aim was to discuss pertinent methods, reporting quality and challenges for future implementation of AI in healthcare, and additionally advise future HEEs.MethodsA systematic literature review was conducted in 2 databases (PubMed and Scopus) for articles published in the last 5 years. Two reviewers performed independent screening, full-text inclusion, data extraction, and appraisal. The Consolidated Health Economic Evaluation Reporting Standards and Philips checklist were used for the quality assessment of included studies.ResultsA total of 884 unique studies were identified; 20 were included for full-text review, covering a wide range of medical specialties and care pathway phases. The most commonly evaluated type of AI was automated medical image analysis models (n = 9, 45%). The prevailing health economic analysis was cost minimization (n = 8, 40%) with the costs saved per case as preferred outcome measure. A total of 9 studies (45%) reported model-based HEEs, 4 of which applied a time horizon >1 year. The evidence supporting the chosen analytical methods, assessment of uncertainty, and model structures was underreported. The reporting quality of the articles was moderate as on average studies reported on 66% of Consolidated Health Economic Evaluation Reporting Standards items.ConclusionsHEEs of AI in healthcare are limited and often focus on costs rather than health impact. Surprisingly, model-based long-term evaluations are just as uncommon as model-based short-term evaluations. Consequently, insight into the actual benefits offered by AI is lagging behind current technological developments. 相似文献
6.
《Gaceta sanitaria / S.E.S.P.A.S》2021,35(4):399-401
Chile's October 2019 popular revolt has again made human rights violations visible in the context of mass mobilizations. In terms of damage to the population's health, multiple eye injuries produced by kinetic impact projectiles and tear bombs against people were reported, leading to an outbreak of unpublished eye injuries worldwide. There was excessive use of chemical weapons, and the totality of the chemicals used has not been transparent. The impact on mental health, especially of the population who lived during dictatorship in the 1970s, is uncertain and, health care was overwhelmed in the most vulnerable geographic areas. It is urgent to establish a timely and transparent system for monitoring such lesions and transparent all chemical compounds in tear-tearing and the composition of kinetic impact projectiles. 相似文献
7.
8.
Taiki Matsunaga Yuki Kamachi Koichi Kinoshita Tetsuya Sakamoto Takuaki Yamamoto 《The Journal of arthroplasty》2021,36(2):429-433
BackgroundCurved periacetabular osteotomy (CPO) is performed via an anterior approach without detachment of the hip abductor muscles. This study aimed to evaluate the abductor muscle status shortly after CPO on magnetic resonance imaging (MRI).MethodsWe prospectively evaluated 38 hips in 38 patients 1 week and 3 months after CPO between October 2017 and July 2019. The status of the abductor muscles was assessed on MRI using the following criteria: grade 0, normal; grade I, strain/edema; grade II, partial tear; and grade III, complete tear. We also evaluated associations between muscle status and patients’ characteristics.ResultsOne week after CPO, the gluteus maximus was classified as grade 0 in all patients. The gluteus medius was grade 0 in 84.2% of patients and grade I in 15.8%. The gluteus minimus was grade I in 55.3% of patients and grade II in 44.7%. Three months after CPO, both the gluteus maximus and gluteus medius were grade 0 in all patients, while the gluteus minimus was still grade I in 47.4%. There were no significant differences between patients with a grade 0 and grade I gluteus minimus at 3 months after CPO in patients’ characteristics (age and body mass index) or clinical scores (Harris Hip Score and Japanese Orthopedics Association score).ConclusionBoth the gluteus minimus and medius showed abnormal appearances on MRI 1 week after CPO, whereas only the gluteus minimus showed abnormalities 3 months after CPO. This abductor muscle status did not affect the postoperative Harris Hip Score or Japanese Orthopedics Association score. 相似文献
9.
《The Journal of arthroplasty》2021,36(9):3226-3232
BackgroundThe average age of patients benefiting from total hip arthroplasty (THA) has been declining. In addition to pain relief, patients seek to return to physical activity. However, the latter may increase polyethylene wear and therefore the potential risk of early aseptic loosening. The introduction of highly crosslinked polyethylene (HXLPE) has reduced wear rates in the general patient population. The objective of this study was to evaluate the influence of impact sports in patients operated with THA using ceramic-on-conventional polyethylene (cPE) versus ceramic-on-HXLPE, in terms of wear and function, with a minimum of five year follow-up.MethodsSixty-eight patients practicing an impact sport (University of California Los Angeles score ≥8) who underwent a primary THA were included: 34 with a ceramic-on-cPE versus 34 with a ceramic-on-HXLPE using the same cementless acetabular and femoral component. Patients were matched-paired by age, sex, BMI, and University of California Los Angeles score. The wear analysis was performed using the IMAGIKA software. The Harris hip score and hip and osteoarthritis outcome score were collected.ResultsThe linear wear rate was statistically higher (P < .0001) in the cPE group (0.13503 ± 0.0630 mm/year) than in the HXLPE group (0.03059 ± 0.0084 mm/year). Postoperatively, the increase in Harris hip score was calculated at 37.64 for the entire cohort and was comparable in both groups (P = .3674). The hip and osteoarthritis outcome score for pain (P = .0009), daily life activities (P = .0016), and quality of life (P = .0179) were significantly higher in the HXLPE group, with, between groups, a difference inferior to the reported minimal clinical important difference. Three patients exhibited signs of periprosthetic osteolysis in the cPE group, one on the femoral side and two on the acetabular side. None were observed in the HXLPE group. No revision for aseptic loosening was reported in both cohorts.ConclusionPatients partaking in impact sports and receiving a ceramic-on-HXLPE THA demonstrated lower wear and osteolysis rates than those having a ceramic-on-cPE THA, with similar functional results. 相似文献
10.
提出一种综合考虑通路局部和全局信息的基因通路富集分析(GIGSEA)方法。首先利用基因相互作用数据,通过基因在通路的局部重要性和在通路数据库的全局特异性计算基因的影响力;然后将基因影响力和表型相关性值融合在一起,计算通路的富集分数;最后通过置换基因富集出统计学显著的通路。将GIGSEA方法运用于肝细胞癌和结肠直肠癌数据集进行风险通路富集,与基因集富集分析方法相比,GIGSEA方法能富集出一些新的相关通路,并排除无关的通路,提高疾病相关通路的富集效果。 相似文献